a company which engages in development of drugs to treat gastroenterological disorders and disease
Industry PharmaceuticalsOther
A.I.dvisor tells us that EVOK and SBFM have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVOK and SBFM's prices will move in lockstep.
Ticker / NAME | Correlation To EVOK | 1D Price Change % | ||
---|---|---|---|---|
EVOK | 100% | +2.48% | ||
SBFM - EVOK | 25% Poorly correlated | +0.39% | ||
CYTH - EVOK | 22% Poorly correlated | -14.63% | ||
SIGA - EVOK | 20% Poorly correlated | -4.69% | ||
ITCI - EVOK | 11% Poorly correlated | -0.67% | ||
AMPH - EVOK | 10% Poorly correlated | -0.92% | ||
More |
Ticker / NAME | Correlation To EVOK | 1D Price Change % |
---|---|---|
EVOK | 100% | +2.48% |
gastroenterological theme (2 stocks) | 76% Closely correlated | +3.58% |
drugs theme (254 stocks) | 11% Poorly correlated | -1.67% |
Pharmaceuticals theme (308 stocks) | 10% Poorly correlated | -1.29% |
Pharmaceuticals: Other theme (235 stocks) | 8% Poorly correlated | -1.52% |
pharmaceuticals theme (159 stocks) | 6% Poorly correlated | -1.90% |